Summit Therapeutics SMMT Investment Purchases
Investment Purchases at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireShortTermInvestments.
The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's investment purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Summit Therapeutics's investment purchases?
- Summit Therapeutics (SMMT) reported investment purchases of $177.29M in Q1 2026.
- What does investment purchases mean?
- Cash spent to purchase short-term investments or marketable securities.
- How do you interpret investment purchases?
- High levels of purchases suggest the company has excess cash to deploy, while low levels may indicate a need to preserve cash for operations.
- How does investment purchases compare across companies?
- Standard for companies with large cash reserves; reflects the conservative nature of the company's treasury policy.